CAPSTONE NATIONAL PARTNERS

Lobbying for ATTERX BIOTHERAPEUTICS · Biotherapeutical development

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Wisconsin · House · Senate · $15,000.00 income · posted May 18, 2026

Lobbying activity 1

Medical/Disease Research/Clinical Labs

FY27 Appropriations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem